Literature DB >> 12074942

Protection against dextran sulfate sodium-induced colitis by microspheres of ellagic acid in rats.

Y Ogawa1, K Kanatsu, T Iino, S Kato, Y I Jeong, N Shibata, K Takada, K Takeuchi.   

Abstract

Ellagic acid (EA), a naturally occurring plant phenol, has the antioxidant and anti-inflammatory activities. In the present study, we examined the effect of EA contained in microspheres on the ulcerative colitis induced experimentally in rats by dextran sulfate sodium (DSS). Experimental colitis was induced in male Fisher 344 rats by daily treatment with 3% DSS solution in drinking water for 7 days. EA of microspheres (mcEA: 1 approximately 10 mg/kg as EA contents) was administered p.o. twice daily for 6 days. In a preliminary study, we found that these microsphere capsules, when administered p.o., are effectively dissolved in the proximal to the ileo-cecal junction and distributed to the terminal ileum and the colon. The ulceration area, colon length, and mucosal myeloperoxidase (MPO) activity as well as thiobarbituric acid-reactive substances (TBARS) were measured on 7th day after the onset of DSS treatment. The DSS treatment for 7 days caused severe mucosal lesions in the colon, accompanied with the increases of MPO activity and TBARS as well as the decreases of body weight gain and colon length. Administration of mcEA reduced the severity of DSS-induced colitis in a dose-dependent manner, and a significant effect was observed at 10 mg/kg, the ED50 being 2.3 mg/kg. This mcEA treatment also significantly mitigated changes in various biochemical parameters in the colonic mucosa induced by DSS. Although plain EA (without using microspheres) was also effective in reducing the severity of DSS-induced colitis, this effect was much less potent as compared with that of mcEA; the ED50 was about 15 times higher than that of mcEA. In addition, a significant effect on DSS-induced colitis was also obtained by intra-rectal administration of superoxide dismutase, an anti-oxidative agent. These results suggest that EA prevents the ulcerative colitis induced by DSS, probably by radical scavenging and/or anti-oxidative actions. The microspheres used in this study may be useful for delivering an orally administered drug specifically to the colon.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12074942     DOI: 10.1016/s0024-3205(02)01737-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  18 in total

1.  Downregulation of electroacupuncture at ST36 on TNF-alpha in rats with ulcerative colitis.

Authors:  Li Tian; Yu-Xin Huang; Min Tian; Wei Gao; Qing Chang
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

Review 2.  Alternative medicines as emerging therapies for inflammatory bowel diseases.

Authors:  Udai P Singh; Narendra P Singh; Brandon Busbee; H Guan; Balwan Singh; Robert L Price; Dennis D Taub; Manoj K Mishra; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Int Rev Immunol       Date:  2012-02       Impact factor: 5.311

Review 3.  Pomegranate extracts and cancer prevention: molecular and cellular activities.

Authors:  Deeba N Syed; Jean-Christopher Chamcheu; Vaqar M Adhami; Hasan Mukhtar
Journal:  Anticancer Agents Med Chem       Date:  2013-10       Impact factor: 2.505

Review 4.  Ellagic acid in suppressing in vivo and in vitro oxidative stresses.

Authors:  Alam Zeb
Journal:  Mol Cell Biochem       Date:  2018-01-31       Impact factor: 3.396

5.  Ameliorative effects of bombesin and neurotensin on trinitrobenzene sulphonic acid-induced colitis, oxidative damage and apoptosis in rats.

Authors:  Alper Akcan; Sebahattin Muhtaroglu; Hulya Akgun; Hizir Akyildiz; Can Kucuk; Erdogan Sozuer; Alper Yurci; Namik Yilmaz
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

6.  Ellagic acid inhibits pancreatic fibrosis in male Wistar Bonn/Kobori rats.

Authors:  Noriaki Suzuki; Atsushi Masamune; Kazuhiro Kikuta; Takashi Watanabe; Kennichi Satoh; Tooru Shimosegawa
Journal:  Dig Dis Sci       Date:  2008-07-25       Impact factor: 3.199

7.  Aggravation by selective COX-1 and COX-2 inhibitors of dextran sulfate sodium (DSS)-induced colon lesions in rats.

Authors:  Mitsuaki Okayama; Shusaku Hayashi; Yoko Aoi; Hikaru Nishio; Shinichi Kato; Koji Takeuchi
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

8.  The effect of ellagic acid on the repair process of periodontal defects related to experimental periodontitis in rats.

Authors:  Figen Öngöz Dede; Şeyma Bozkurt Doğan; Umut Balli; Mustafa Cenk Durmuşlar; Bahattin Avci; Kanat Gülle; Meryem Akpolat Ferah
Journal:  J Appl Oral Sci       Date:  2021-09-27       Impact factor: 2.698

Review 9.  Phytochemicals Targeting JAK-STAT Pathways in Inflammatory Bowel Disease: Insights from Animal Models.

Authors:  Sun Young Moon; Kwang Dong Kim; Jiyun Yoo; Jeong-Hyung Lee; Cheol Hwangbo
Journal:  Molecules       Date:  2021-05-10       Impact factor: 4.411

10.  A review on the anti-inflammatory activity of pomegranate in the gastrointestinal tract.

Authors:  Elisa Colombo; Enrico Sangiovanni; Mario Dell'agli
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-14       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.